Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
[146] synthesized a particular type of ceria NPs to load miR-224-5p with urchin-like structure, which enhanced the stability of miR-224-5p and increased the cellular uptake
We provide evidence that this targeting concept can be used to antagonize NMDA receptors specifically in GLP-1-receptor-positive neurons to reverse obesity and correct symptoms of cardiometabolic diseases in preclinical obesity models
market size methodology To calculate an estimated market share of GLP-1 agonist products in the U.S., we collected data on market sizes of these products from the following sources: Sources Cleveland Clinic, GLP-1 Agonists Grand View Research, GLP-1 Receptor Agonist Market Size and Share JP Morgan, The Increase in Appetite for Obesity Drugs Grand View Research, U.S
PLoS ONE, 11 , e0167902
US$ 26.03
US$ 25.26
US$ 20.73
US$ 23.51
US$ 26.27
